SII, Bharat Biotech want to increase production to meet domestic, foreign demand
: Tamil Nadu reported 2,194 new infections and nine fatalities on Sunday, pushing the caseload to 8,79,473 and the death toll to 12,670, said the Health Department. The number of cases crossed the 2,000-mark on March 27; 1,000-mark on March 19 after over 80 days when it touched 1,087, a bulletin said. According to it, recoveries mounted to 8,53,733 today with 1,270 patients being discharged, leaving 13,070 active cases. Chennai accounted for most of the new infections with 833 cases, taking the aggregate to 2,46,339. The metropolis also leads in the number of fatalities with 4,230. A total of 85,350 samples were tested today, pushing the cumulative number of specimen examined so far to 1,93,47,797. Chengalpet reported 188 cases, Coimbatore 180, Thiruvallur 117 and Thanjavur 108. As many as 25 districts reported fresh infections in double digits, the bulletin said.
Total 23,58,731 vaccine doses were given in the last 24-hours, which marks the 69th day of vaccination
Here's a selection of Business Standard opinion pieces for the day
Govt must fast-track approval process, fix distribution issues
India is, however, not officially banning Covid-19 vaccine exports. "This is a temporary move until the supply situation stabilises in the country," said a person close to the development
The mansion is one of the largest residences in the neighborhood and measures about 25,000 square feet (2,322 square meters), the equivalent of about 24 average English homes
Vaccine makers asked to send more doses to central government on priority
Maharashtra on Tuesday reported 28,699 new COVID-19 cases and 132 deaths, the state health department said.
So far, only those above 45 who had certain co-morbidities were allowed to take the vaccine after producing a letter from a registered doctor
Experts say controlling spoilage with 10-dose vials may give vax drive a shot in the arm
Two of the largest city-based realty players -- the IPO-bound Macrotech Developers, earlier known as Lodha Group, and K Raheja Corp -- said they would pay for the vaccinations of their employees.
Here's a selection of Business Standard opinion pieces for the day
We must pull out all the stops to win the race against the virus. And trust each other to do the right thing
The speed record of Covid-19 vaccine launches is extraordinary
Piramal said it will also absorb the cost of vaccinating immediate family members of the employees
Here's a selection of Business Standard opinion pieces for the day
Rs 150/dose not ceiling price; cost to be fixed individually
Covaxin was India's first indigenously developed vaccine to be approved, controversially under "clinical trial mode" in the first week of January
There are several reasons why we are not yet, as Union Health Minister Harsh Vardhan claimed recently, in the "the endgame" of the pandemic in this country